dates for CE credit: 10/14/2020
Insulin has been used for nearly 100 years, longer than any other diabetes medication therapy. It is estimated that approximately 30% of people with diabetes take insulin. All people with type 1 diabetes need insulin, and the number of people with type 2 diabetes that use insulin varies. Over the past century, the types of insulin and the recommendations for treatment have changed dramatically. This session will focus on the basics of insulin therapy, including a review of normal insulin physiology, available and future insulin products, barriers and considerations when selecting insulin as monotherapy or combination therapy, and medication taking for optimal person-centered diabetes care.
80% of learners will state one thing they will change about their practice on their evaluation surveys based on the content of this activity.
At the end of this presentation,
participants will be able to:
-- Discuss current guidelines and recommendations for insulin therapy
-- Compare the various insulin products available, including the pharmacokinetic and pharmacodynamic parameters of insulin formulations and delivery methods
-- Review and develop an individualized patient care plan to overcome and promote optimal medication taking
This recording of a live presentation
is a knowledge-based
ADCES Webinars are designed for
individual or groups of diabetes care and education specialists, including RNs,
RDs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physicians, Physician
Assistants, and other health care providers interested in staying up to date on
current practices of care for people with diabetes and other related conditions.
Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Associate Director of Experiential Education
Associate Professor of Pharmacy Practice
Midwestern University, Chicago College of Pharmacy
Downers Grove, Illinois
support of improving patient care, the Association of Diabetes Care &
Education Specialists is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy
Education (ACPE), and the American Nurses Credentialing Center (ANCC) to
provide continuing education for the healthcare team.
activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional
Continuing Education (IPCE) credit(s) for learning and change.
Council for Pharmacy Education (ACPE)
Universal Activity Number is JA4008258-21-018-H01-P
activity has been approved for 1.5 contact hour(s).
This statement contains information provided to NABP from
the Accreditation Council for Pharmacy Education (ACPE) via CPE
Monitor®. ACPE policy states paper and/or
electronic statements of credit may no longer be distributed directly to
learners as proof of ACPE credit. The official record of credit may be located
in the learner’s e-profile in CPE Monitor.
Medical Association (AMA)
of Diabetes Care & Education Specialists designates this enduring
material for a maximum of 1.5
AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this
activity for a maximum of 1.5
ANCC contact hour(s). This activity discusses 0.55 contact hour(s) of pharmacotherapeutic
Association of Diabetes Care & Education Specialists is approved by the
California Board of Registered Nursing, Provider Number 10977, for 1.5 contact
Academy of PAs (AAPA)
Association of Diabetes Care & Education Specialists has been
authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME
credit for activities planned in accordance with AAPA CME Criteria. This
activity is designated for 1.5
AAPA Category 1 CME credit(s). PAs should only claim credit commensurate with
the extent of their participation.
on Dietetic Registration (CDR)
Credentialed Practitioners will receive 1.5 Continuing Professional Education unit(s) (CPEU)
for completion of this activity.
Completion of this RD/DTR profession-specific or IPCE
activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related
but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate
with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs
are to select activity type 102 in their Activity Log. Performance Indicator
selection is at the learner’s discretion.
Certified Diabetes Care and Education
To satisfy the requirements for renewal
of certification for the Certification Board for Diabetes Care and Education
(CBDCE), continuing education activities must be diabetes related and approved
by a provider on the CBDCE list of Approved Providers (www.cbdce.org).
CBDCE does not approve continuing education. The Association of Diabetes Care
& Education Specialists is on the CBDCE list of Approved
Board Certified Advanced Diabetes
ADCES is the administering body for the
Advanced Diabetes Management credentials. Continuing education programs offered
by ADCES can be used toward fulfilling BC-ADM Certification and recertification
Other Health Professionals
It is the responsibility of each
participant to determine if the program meets the criteria for re-licensure or
recertification for their discipline.
accordance with Joint Accreditation criteria, the Association of Diabetes Care
& Education Specialists (ADCES) must ensure that anyone in a position to
control the content of the educational activity (planners and
speakers/authors/discussants/moderators) has disclosed all relevant financial
relationships with any commercial interest.
Joint Accreditation also requires that
ADCES manage any reported conflict and eliminate the potential for bias during
the educational activity. Any conflicts noted below have been managed to our
satisfaction. The disclosure information is intended to identify any commercial
relationships and allow learners to form their own judgments. However, if you
perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Susan Cornell, PharmD, CDCES, FAPhA, FADCES - Speakers Bureau: Novo Nordisk, Abbott Diabetes Care; Consultant: Novo Nordisk, Becton Dickinson Advanced Practitioner Advisory Board
Jodi Lavin-Tompkins, MSN, RN, CDCES,
BC-ADM, has no relevant financial disclosures to report.
Joanne Rinker, MS, RDN,
CDCES, LDN, FADCES, has no relevant financial disclosures to report.
Eileen D. Ward, PharmD, BCACP, TTS, has
no relevant financial disclosures to report.
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure of Relevant Financial
Relationships and Mechanism to Identify and Resolved Conflicts of
Undertaking review of the educational
activity to evaluate for potential bias, balance in presentation,
evidence-based content or other indicators of integrity, and absence of
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity's CE credits expire (whichever comes
discounts are available and will be automatically applied at check-out when the
desired quantity is selected
Groups of 4-9: 10% off
Groups of 10-19: 20% off
Groups of 20-29: 30% off
Groups of 30+: Contact firstname.lastname@example.org
to get a custom quote.
CBs and LNGs: Please contact us at email@example.com
to order a recorded webinar for a group viewing.